The Effective Health Care Program Stakeholder Guide
Appendix A. Standardized Selection Criteria for Topics
- Represents a health care drug, intervention, device, or technology available (or soon to be available) in the United States.
- Relevant to Medicare, Medicaid, the Children's Health Insurance Program (CHIP), and other Federal health care programs.
- Represents a significant disease burden; affects a large proportion of the population or a priority population (e.g., children, elderly adults, low-income, rural/inner city, minorities, or other individuals with special health care or access issues).
- Is of high public interest; affects health care decisionmaking, outcomes, or costs for a large proportion of the U.S. population or for a priority population in particular.
- Was nominated/strongly supported by one or more stakeholder groups.
- Represents important uncertainty for decisionmakers.
- Incorporates issues surrounding both clinical benefits and potential clinical harms.
- Represents important variation in clinical care or controversy in what constitutes appropriate clinical care.
- Represents high costs due to common use, high unit costs, or high associated costs to consumers, patients, health care systems, or payers.
- Avoids potential for redundancy (i.e., is not already covered by an available or soon-to-be available high-quality systematic review by AHRQ or others).
- Effectively utilizes existing research and knowledge by considering—
- Adequacy (type and volume) of research for conducting a systematic review.
- Newly available evidence (particularly for updates or new technologies).
- Has potential for significant health impact:
- To improve health outcomes.
- To reduce significant variation in clinical practices known to be related to quality of care.
- To reduce unnecessary burden on those with health care problems.
- Has potential for significant economic impact:
- To reduce unnecessary or excessive costs.
- Has potential for change:
- The proposed topic exists within a clinical, consumer, or policymaking context that is amenable to evidence-based change.
- A product from the EHC Program could be an appropriate vehicle for change.
- Has potential risk from inaction:
- Unintended harms from lack of prioritization of a nominated topic.
- Addresses inequities and vulnerable populations (including issues for patient subgroups).
- Addresses a topic that has clear implications for resolving important dilemmas in health and health care decisions made by one or more stakeholder groups.